Michelle Dawson posts

Post published on Bluesky on 26 Apr 2026 11:27

Bluesky DOI work crossref Extract quoted in the post External link integrated into the post

"If blinding is inadequate, stronger placebo effects might be observed in the active treatment group and weaker placebo effects in the placebo group due to divergent expectanices surrounding receiving the desired treatment" www.sciencedirect.com/science/arti... review, autism-relevant

View on Bluesky

Structured cited links

1 cited resource

DOI work Fetched Post crossref

Joseph J Taylor, Balázs Szigeti, Noah D Silverberg, Masoud Ahmadzad-Asl, Marina Kare, Ryan Webler, Diana K Orsini, Joshua D Rosenblat, et al. (2026). Measuring and appraising placebo effects in clinical trials: contemporary challenges and approaches in psychiatry. The Lancet Psychiatry, 13(5), 426-440. Elsevier BV.

Publication date
May 2026
Identifier
10.1016/s2215-0366(26)00018-0
Authors
Joseph J Taylor, Balázs Szigeti, Noah D Silverberg, Masoud Ahmadzad-Asl, Marina Kare, Ryan Webler, Diana K Orsini, Joshua D Rosenblat, Tom Bschor, Christopher Baethge, Mark Sinyor, Timothy R Nicholson, Tor D Wager, Matthew J Burke
Source
The Lancet Psychiatry
Details
13(5), 426-440
Reference type
article
Publisher
Elsevier BV
Metadata source
crossref

Abstract

Placebo effects are among the greatest paradoxes in medical research. Although more data on placebos are available from placebo-controlled trials than…

Study authors in this cited reference